Chief R&D Officer
David Nicholson graduated in pharmacology, earning his B.Sc. from the University of Manchester and his Ph.D. from the University of Wales. He has worked in the pharmaceutical industry for Beecham-Wülfing in Germany. Various positions of increasing seniority in the UK, the Netherlands and the USA with Organon a Business Unit of Akzo Nobel. Ultimately he became Executive Vice President, Research & Development, and member of the Organon Executive Management Committee. He has also worked for Schering-Plough, as Senior Vice President, responsible for Global Project Management and Drug Safety and at Merck as Senior Vice President, Licensing and Knowledge Management. As an integration team member, he played a role in the strategic mergers of Organon BioSciences and Schering-Plough as well as of Schering-Plough and Merck and Forest with Actavis. David Nicholson was also Head of R&D and a member of the Executive Committee at Bayer Crop Science. He has been a member of Biotech Boards, including Actinium Pharmaceuticals.